RxDoctor Payments Data

Robin Lipski, DO

Family Medicine · Livonia, MINPI 1285676718

Payments from drug & device makers

$607in general payments, 2019–2025

Across 38 payments — averaging $15.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$141
  • Johnson & Johnson$92
  • Indivior Inc.$72
  • Takeda Pharmaceuticals U.S.A., Inc.$67
  • Orexo US, Inc.$49
  • Amgen$35
  • plus $150 from 8 others

What the payments were for

  • Food & beverage$607100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$607 in reported general payments places this provider in the 60th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$28,361
Medicare patients
57
Services billed
559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$67,706
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl285$65,347
Trelegy ElliptaFluticasone/Umeclidin/Vilanter71$60,631
MounjaroTirzepatide35$56,300
JanuviaSitagliptin Phosphate50$54,909
JardianceEmpagliflozin31$46,280
InvokanaCanagliflozin37$45,285
TrulicityDulaglutide22$38,926
SuboxoneBuprenorphine Hcl/Naloxone Hcl49$32,097
FarxigaDapagliflozin Propanediol19$26,119
Nurtec OdtRimegepant Sulfate12$23,963
LinzessLinaclotide33$19,321
XareltoRivaroxaban16$12,917
Bydureon BciseExenatide Microspheres13$10,793
Lantus SolostarInsulin Glargine,hum.Rec.Anlog62$9,770

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$20$95,22657 claims
GSKTrelegy Ellipta, Anoro Ellipta$32$69,79584 claims
Johnson & JohnsonInvokana, Xarelto$92$58,20253 claims
Indivior Inc.Suboxone$72$32,09749 claims
PfizerNurtec Odt, Prempro$141$26,58623 claims
AbbVieLinzess, Synthroid$22$20,25644 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Livonia

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →